Important exposure controls for protection against antineoplastic agents: Highlights for oncology health care workers
Authors:
- 3 February 2018
- journal article
- research article
- Published by SAGE Publications in WORK: A Journal of Prevention, Assessment & Rehabilitation
- Vol. 59 (1) , 165-172
Abstract
BACKGROUND: A great number of antineoplastic drugs (ANPDs) are used globally in cancer treatment. Due to their adverse health effects, occupational exposure to ANPDs is considered a potential health risk to health care workers. OBJECTIVE: The currentKeywords
This publication has 40 references indexed in Scilit:
- Occupational exposure to anti-cancer drugs: A review of effects of new technologyJournal of Oncology Pharmacy Practice, 2013
- Occupational Exposure to Antineoplastic Drugs: Identification of Job Categories Potentially Exposed throughout the Hospital Medication SystemSafety and Health at Work, 2011
- The PhaSeal® system: Impact of its use on workplace contamination and duration of chemotherapy preparationJournal of Oncology Pharmacy Practice, 2011
- Occupational health and safety of personnel handling chemotherapeutic agents in Greek hospitalsEuropean Journal of Cancer Care, 2010
- Safe Handling of Hazardous Drugs: Are You Protected?Clinical Journal of Oncology Nursing, 2009
- Genotoxicity assessment in oncology nurses handling anti-neoplastic drugsMutagenesis, 2007
- Investigating genetic damage in workers occupationally exposed to methotrexate using three genetic end-pointsMutagenesis, 2005
- Chemotherapy-Handling Practices of Outpatient and Office-Based Oncology NursesOncology Nursing Forum, 2003
- Exposure of Pharmacy Technicians to Antineoplastic Agents: Reevaluation after Additional Protective MeasuresArchives of Environmental Health: An International Journal, 1997
- Acute Occupational Exposure to Antineoplastic AgentsJournal of Occupational and Environmental Medicine, 1988